Citius OncologyCTOR 10 Days Payable is 2,680.64 as of Mar. 2026. GuruFocus rates CTOR with a GF Score™ of 10/100. The stock has 2 warning signs investors should review. Among 923 Drug Manufacturers companies, Citius Oncology ranks better than 98.27% on this metric.
The historical rank and industry rank for Citius Oncology's Days Payable or its related term are showing as below:
CTOR'
s Days Payable Range Over the Past 10 Years
Min: 0 Med: 0 Max: 3193.46
Current: 3193.46
During the past 4 years, Citius Oncology's highest Days Payable was 3193.46. The lowest was 0.00. And the median was 0.00.
CTOR's Days Payable is ranked better than 98.27% of 923
companies
in the Drug Manufacturers industry
Industry Median: 90.98
vs CTOR: 3193.46
Citius Oncology's Days Payable
increased
from Mar. 2025 (0.00) to Mar. 2026 (2,680.64).
It may suggest that Citius Oncologydelayed paying its suppliers.
Citius Oncology Days Payable Related Terms
Citius Oncology Days Payable Historical Data
* Premium members only.
The historical data trend for Citius Oncology's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Citius Oncology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Citius Oncology Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Citius Oncology's Days Payable distribution charts can be found below:
* The bar in red indicates where Citius Oncology's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Citius Oncology's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Citius Oncology (CTOR) has a Days Payable of 2,680.64 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Citius Oncology and its competitors. According to the industry distribution chart, Citius Oncology ranks #16 out of 923 companies in the Drug Manufacturers industry, placing it in the top 1.7%.
Is Citius Oncology's Days Payable too high?
Citius Oncology's current Days Payable is 2,680.64. The Drug Manufacturers industry median Days Payable is 90.98. Citius Oncology's value of 2,680.64 is 2846.4% above this industry median. Based on the distribution chart, Citius Oncology ranks #16 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Citius Oncology has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Citius Oncology's Days Payable compare to INCR and BGM?
According to the Drug Manufacturers industry distribution chart, Citius Oncology ranks #16 out of 923 companies for Days Payable. This places Citius Oncology in the top 2% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.98. Citius Oncology's value of 2,680.64 is 2846.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Citius Oncology's current Days Payable of 2,680.64 is 2846.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Citius Oncology and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Citius Oncology's current Days Payable is 2,680.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Citius Oncology stock overvalued right now?
Citius Oncology (CTOR) has a current Days Payable of 2,680.64. The current Days Payable is 2,680.64 and 2846.4% above the Drug Manufacturers industry median of 90.98. Citius Oncology's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Citius Oncology (CTOR), the current Days Payable is 2,680.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.
10GF Score
Get the complete analysis for CTOR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CTOR has been successfully added to your 
